Shikonin enhances efficacy of a gene-based cancer vaccine via induction of RANTES

Journal of Biomedical Science

Volumn 19, Issue 1, 2012, Pages

  Chen, Hui Ming ^a,b   Wang, Pi Hsueh ^b   Aravindaram, Kandan ^b   Chen, Yun Hsiang ^b   Yu, Hsiu Hui ^b   Yang, Wen Chin ^b   Yang, Ning Sun ^b,c,d,e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^e NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; FLUORESCEIN ISOTHIOCYANATE; GLYCOPROTEIN GP 100; MESSENGER RNA; RANTES; SHIKONIN; TUMOR ANTIGEN; CCL5 PROTEIN, HUMAN; CCL5 PROTEIN, MOUSE; DNA VACCINE; MELANOCYTE PROTEIN PMEL 17; NAPHTHOQUINONE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNIZATION; CELL MIGRATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE GUN IMMUNIZATION; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; LYMPHATIC DRAINAGE; MALE; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CULTURE; SKIN DEFECT; SKIN SENSITIZATION; SKIN TEST; TISSUE INJURY; ANIMAL; BIOSYNTHESIS; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; SKIN TUMOR; TUMOR CELL LINE;

LITHOSPERMUM ERYTHRORHIZON;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CANCER VACCINES; CELL LINE, TUMOR; CHEMOKINE CCL5; DENDRITIC CELLS; GP100 MELANOMA ANTIGEN; HUMANS; MALE; MICE; NAPHTHOQUINONES; SKIN NEOPLASMS; VACCINES, DNA;

EID: 84859647259     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-19-42     Document Type: Article

References (43)

1. Inhibition of lipopolysaccharide and interferon-gamma-induced expression of inducible nitric oxide synthase and tumor necrosis factor-alpha by Lithospermi radix in mouse peritoneal macrophages. Chung HS, Kang M, Cho C, Park S, Kim H, Yoon YS, Kang J, Shin MK, Hong MC, Bae H, J Ethnopharmacol 2005 102 412 417 10.1016/j.jep.2005.06.028 16054790 (Pubitemid 41571849)
2. Tissue Array Transgene Expression System for the Evaluation of Effect of Medicinal Herbs on Wound-healing. Jeng-Hwan Wang K-FL, Benson Spencer A, Show-Jane Sun, Wei-Ming Cheng, Sheng-Yang Wang, Lie-Fen Shyur, Ning-Sun Yang, J Genet Mol Biol 2003 14 133 144
3. Anti-inflammatory effect of Arnebia euchroma root extracts in rats. Kaith BS, Kaith NS, Chauhan NS, J Ethnopharmacol 1996 55 77 80 10.1016/S0378-8741(96) 01477-8 9121171 (Pubitemid 27051184)
4. Granulomatous tissue formation of shikon and shikonin by air pouch method. Sakaguchi I, Tsujimura M, Ikeda N, Minamino M, Kato Y, Watabe K, Yano I, Kaneda K, Biol Pharm Bull 2001 24 650 655 10.1248/bpb.24.650 11411553 (Pubitemid 32586655)
5. Cellular pharmacology studies of shikonin derivatives. Chen X, Yang L, Oppenheim JJ, Howard MZ, Phytother Res: PTR 2002 16 199 209 10.1002/ptr.1100 12164262 (Pubitemid 34534943)
6. A shikonin derivative, beta-hydroxyisovalerylshikonin, is an ATP-non-competitive inhibitor of protein tyrosine kinases. Nakaya K, Miyasaka T, Anticancer Drugs 2003 14 683 693 14551501 (Pubitemid 37357692)
7. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Han W, Li L, Qiu S, Lu Q, Pan Q, Gu Y, Luo J, Hu X, Mol Cancer Ther 2007 6 1641 1649 10.1158/1535-7163.MCT-06-0511 17513612 (Pubitemid 46954031)
8. Shikonins, phytocompounds from Lithospermum erythrorhizon, inhibit the transcriptional activation of human tumor necrosis factor alpha promoter in vivo. Staniforth V, Wang SY, Shyur LF, Yang NS, J Biol Chem 2004 279 5877 5885 14645256 (Pubitemid 38220620)
9. Inhibition of tumor necrosis factor-alpha through selective blockade of Pre-mRNA splicing by shikonin. Chiu SC, Yang NS, Mol Pharmacol 2007 71 1640 1645 10.1124/mol.106.032821 17360831 (Pubitemid 47018066)
10. Breaking tolerance to tumors with dendritic cell-based immunotherapy. Mende I, Engleman EG, Ann N Y Acad Sci 2005 1058 96 104 10.1196/annals.1359.018 16394129
11. Role of Langerhans cells in cutaneous protective immunity: is the reappraisal necessary? Asahina A, Tamaki K, J Dermatol Sci 2006 44 1 9 10.1016/j.jdermsci.2006.07.002 16949255 (Pubitemid 44310993)
12. Langerhans cells as outposts of the dendritic cell system. Warfel AH, Thorbecke GJ, Belsito DV, Adv Exp Med Biol 1993 329 469 480 10.1007/978-1-4615- 2930-9-79 8379412 (Pubitemid 23199670)
13. Dendritic cell immunotherapy: mapping the way. Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ, Nat Med 2004 10 475 480 10.1038/nm1039 15122249 (Pubitemid 38667904)
14. DNA-based immunization by in vivo transfection of dendritic cells. Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD Jr, Nat Med 1996 2 1122 1128 10.1038/nm1096-1122 8837611 (Pubitemid 26338632)
15. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. Porgador A, Irvine KR, Iwasaki A, Barber BH, Restifo NP, Germain RN, J Exp Med 1998 188 1075 1082 10.1084/jem.188.6.1075 9743526 (Pubitemid 28443331)
16. Novel chemotactic-antigen DNA vaccine against cancer. Zhang S, Zhang Y, Future Oncol 2008 4 299 303 10.2217/14796694.4.2.299 18407741 (Pubitemid 351715786)
17. Drug-inducible, dendritic cell-based genetic immunization. Timares L, Safer KM, Qu B, Takashima A, Johnston SA, J Immunol 2003 170 5483 5490 12759425 (Pubitemid 36617836)
18. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Raz E, Carson DA, Parker SE, Parr TB, Abai AM, Aichinger G, Gromkowski SH, Singh M, Lew D, Yankauckas MA, et al. Proc Natl Acad Sci USA 1994 91 9519 9523 10.1073/pnas.91.20.9519 7937799 (Pubitemid 24297946)
19. DNA vaccines: immunology, application, and optimization*. Gurunathan S, Klinman DM, Seder RA, Annu Rev Immunol 2000 18 927 974 10.1146/annurev.immunol.18.1.927 10837079 (Pubitemid 30365401)
20. Transgenic expression of human gp100 and RANTES at specific time points for suppression of melanoma. Aravindaram K, Yu HH, Lan CW, Wang PH, Chen YH, Chen HM, Yagita H, Yang NS, Gene Ther 2009 16 1329 1339 10.1038/gt.2009.90 19626052
21. RANTES: a versatile and controversial chemokine. Appay V, Rowland-Jones SL, Trends Immunol 2001 22 83 87 10.1016/S1471-4906(00)01812-3 11286708 (Pubitemid 32667526)
22. Large induction of the chemotactic cytokine RANTES during cutaneous wound repair: a regulatory role for nitric oxide in keratinocyte-derived RANTES expression. Frank S, Kampfer H, Wetzler C, Stallmeyer B, Pfeilschifter J, Biochem J 2000 347 Pt 1 265 273 10727427 (Pubitemid 30199066)
23. DNA immunization targeting the skin: molecular control of adaptive immunity. Tuting T, Storkus WJ, Falo LD Jr, J Invest Dermatol 1998 111 183 188 10.1046/j.1523-1747.1998.00261.x 9699714 (Pubitemid 28354700)
24. A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells. Xiang J, Huang H, Liu Y, J Immunol 2005 174 7497 7505 15944248 (Pubitemid 40806252)
25. Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking. Chen X, Murakami T, Oppenheim JJ, Howard OM, Blood 2005 106 2409 2416 10.1182/blood-2005-03-0854 15956285 (Pubitemid 41510814)
26. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. Stoitzner P, Holzmann S, McLellan AD, Ivarsson L, Stossel H, Kapp M, Kammerer U, Douillard P, Kampgen E, Koch F, et al. J Invest Dermatol 2003 120 266 274 10.1046/j.1523-1747.2003.12042.x 12542532 (Pubitemid 36513077)
27. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS, J Clin Invest 1998 101 1614 1622 10.1172/JCI1647 9541491 (Pubitemid 28198490)
28. Chemokine-mediated migration of skin-derived stem cells: predominant role for CCL5/RANTES. Kroeze KL, Jurgens WJ, Doulabi BZ, van Milligen FJ, Scheper RJ, Gibbs S, J Invest Dermatol 2009 129 1569 1581 10.1038/jid.2008.405 19122644
29. Cytokine production in a model of wound healing: the appearance of MIP-1, MIP-2, cachectin/TNF and IL-1. Fahey TJ, Sherry B, Tracey KJ, van Deventer S, Jones WG, Minei JP, Morgello S, Shires GT, Cerami A, Cytokine 1990 2 92 99 10.1016/1043-4666(90)90002-B 2104219
30. Accelerative effect of shikonin, alkannin and acetylshikonin on the proliferation of granulation tissue in rats. Ozaki Y, Ohno A, Saito Y, Satake M, Biol Pharm Bull 1994 17 1075 1077 10.1248/bpb.17.1075 7820111 (Pubitemid 24276344)
31. Effect of shikonin on human breast cancer cells proliferation and apoptosis in vitro. Hou Y, Guo T, Wu C, He X, Zhao M, Yakugaku zasshi: J Pharmaceut Soc Jpn 2006 126 1383 1386 10.1248/yakushi.126.1383 (Pubitemid 46089900)
32. Shikonin exerts antitumor activity via proteasome inhibition and cell death induction in vitro and in vivo. Yang H, Zhou P, Huang H, Chen D, Ma N, Cui QC, Shen S, Dong W, Zhang X, Lian W, et al. Int J Cancer 2009 124 2450 2459 10.1002/ijc.24195 19165859
33. Immunomodulatory effects of phytocompounds characterized by in vivo transgenic human GM-CSF promoter activity in skin tissues. Su PF, Staniforth V, Li CJ, Wang CY, Chiao MT, Wang SY, Shyur LF, Yang NS, J Biomed Sci 2008 15 813 822 10.1007/s11373-008-9266-7 18622761
34. Differential functional genomic effects of anti-inflammatory phytocompounds on immune signaling. Chiu SC, Tsao SW, Hwang PI, Vanisree S, Chen YA, Yang NS, BMC Genomics 2010 11 513 10.1186/1471-2164-11-513 20868472
35. Induction of RANTES by TWEAK/Fn14 interaction in human keratinocytes. Jin L, Nakao A, Nakayama M, Yamaguchi N, Kojima Y, Nakano N, Tsuboi R, Okumura K, Yagita H, Ogawa H, J Invest Dermatol 2004 122 1175 1179 10.1111/j.0022-202X. 2004.22419.x 15140220 (Pubitemid 38651092)
36. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S, Biochim Biophys Acta 2011 1813 878 888 10.1016/j.bbamcr.2011.01.034 21296109
37. Cutting edge: RANTES regulates Fas ligand expression and killing by HIV-specific CD8 cytotoxic T cells. Hadida F, Vieillard V, Mollet L, Clark-Lewis I, Baggiolini M, Debre P, J Immunol 1999 163 1105 1109 10415001 (Pubitemid 29352721)
38. The role of RANTES as a crucial downstream cytokine in calcineurin-dependent VSMC apoptosis stimulated by INFgamma and CD40L. Peng YD, Cheng LX, Zeng QT, Shi Y, Bao XX, Mao XB, Ji QW, Li SN, Guo M, Liang ZS, Wu TC, Cell Biol Int 2010 34 447 453 10.1042/CBI20090301 20132097
39. Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. Belyakov IM, Hammond SA, Ahlers JD, Glenn GM, Berzofsky JA, J Clin Invest 2004 113 998 1007 15057306 (Pubitemid 38544121)
40. Topical immunomodulation in dermatology: potential of toll-like receptor agonists. Hengge UR, Ruzicka T, Dermatol Surg 2004 30 1101 1112 10.1111/j.1524-4725.2004.30335.x 15274700 (Pubitemid 39120673)
41. DNA vaccines for viral diseases. Davis HL, McCluskie MJ, Microb Infect/Institut Pasteur 1999 1 7 21 10.1016/S1286-4579(99)80009-4 (Pubitemid 29364907)
42. Bell E, Cytokines: TWEAK and TNF: Yin and Yang in innate immunit 2006
43. TWEAK attenuates the transition from innate to adaptive immunity. Maecker H, Varfolomeev E, Kischkel F, Lawrence D, LeBlanc H, Lee W, Hurst S, Danilenko D, Li J, Filvaroff E, et al. Cell 2005 123 931 944 10.1016/j.cell.2005.09.022 16325585 (Pubitemid 41721037)